Aeterna Zentaris
OTC: CSCIDSummerville, US · Ontario, Canada corporation
Find your way into Aeterna Zentaris
Sign up to see every warm intro you have to Aeterna Zentaris
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Aeterna Zentaris team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Coscien Bio develops natural-based active ingredients derived from oats — including oat beta glucan, oat avenanthramides, and oat oil — for use in skincare, health, and wellness applications. Its ingredients are supplied to consumer brands and developed for cosmeceutical, nutraceutical, and pharmaceutical products.
Founders & leadership
MV
Michael V. WardExecutive
LA
Leslie AuldExecutiveAuld has worked in financial operations roles within the technology and healthcare industries.
KP
Klaus PauliniExecutive
RS
Robin Smith HokeNamed on SEC filing
GL
Gerard LimogesNamed on SEC filing
NA
Nicola AmmerNamed on SEC filing
Board
BN
Brent NortonBoard director
CE
Carolyn EgbertBoard director
Reported raises · per SEC filings
Form D private placements$9.5M disclosed across 2 rounds · 2019–2020
▶$4.5MraisedMar 2020 · 3 investors · PharmaceuticalsRule 506(b)
▶$4.5MraisedMar 2020 · 3 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Klaus PauliniExecutive Officer, Director
- Leslie AuldExecutive Officer
- Nicola AmmerExecutive Officer
- Carolyn EgbertDirector
- Robin Smith HokeDirector
- Gerard LimogesDirector
- Brent NortonDirector
- Gilles GagnonDirector
- Offering amount
- $4.5M
- Amount sold
- $4.5M
- Sales commissions
- $371.3K
- Placement agents
- H.C. Wainwright & Co., LLC
- First sale
- Feb 2020
- Incorporated
- Corporation, Canada (federal Level)
- Federal exemptions
- 06b
▶$5MraisedOct 2019 · 4 investors · PharmaceuticalsRule 506(b)
▶$5MraisedOct 2019 · 4 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Michael V. WardExecutive Officer
- Leslie AuldExecutive Officer
- Klaus PauliniExecutive Officer
- Brent NortonDirector
- Carolyn EgbertDirector
- Robin Smith HokeDirector
- Gerard LimogesDirector
- Nicola AmmerExecutive Officer
- Offering amount
- $5M
- Amount sold
- $5M
- Sales commissions
- $349.1K
- Placement agents
- Maxim Group LLC
- First sale
- Sep 2019
- Incorporated
- Corporation, Canada (federal Level)
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
In the news
Frequently asked questions
- What does Aeterna Zentaris do?
- Coscien Bio develops natural-based active ingredients derived from oats — including oat beta glucan, oat avenanthramides, and oat oil — for use in skincare, health, and wellness applications. Its ingredients are supplied to consumer brands and developed for cosmeceutical, nutraceutical, and pharmaceutical products.
- How much funding has Aeterna Zentaris raised?
- Aeterna Zentaris has disclosed $9.5M raised across 2 rounds.
- Where is Aeterna Zentaris headquartered?
- Aeterna Zentaris is headquartered in Summerville, US.